Integra LifeSciences Holdings Corporation (IART) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and thank you for standing by. Welcome to the Integra Life Science Second Quarter 2025 Financial Results Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I'd like to hand the conference over to your first speaker today, Chris Ward, Senior Director, Investor Relations. Please go ahead. Good morning, and thank you for joining the Integral Life Science of Second Quarter 2025 Earnings Conference Call. With me on the call are Melissa Pohl, President and Chief Executive Officer, and Leah Knight, Chief Financial Officer. Earlier this morning, we issued a press release announcing our second quarter 2025 financial results. The release and corresponding earnings presentation which we will reference during the call, are available at integralife.com under Investor Events and Presentations in a file named Second Quarter 2025 Earnings Call Presentations. Before we begin, I want to remind you that many of the statements made during this call may be considered forward-looking. Factors that could cause actual results to differ materially are discussed in the company's Exchange Act reports that are filed with the SEC and in the loop. Also in our prepared remarks, we will reference reported inorganic revenue growth. organic revenue growth excludes the effects of foreign currency acquisition and divestiture. Unless otherwise stated, all disaggregated and franchise-level revenue growth rates are based on organic perfo...